Oral Answers to Questions

Debate between Jane Ellison and Diana Johnson

Tuesday 28th February 2017 Commons Chamber

[Jane Ellison]

The Government have been very clear on a number of occasions that we recognise the pressures in the system and additional money has been made available through the social care precept. We are well aware of the pressures in the system and, as my right hon. Friend says, the long-term need for more integration—the Chief Secretary has already referred to the better care fund—but his point is well made.

[Diana Johnson (Kingston upon Hull North) (Lab)]

How can it be right that the local authorities under the most pressure in terms of social care can raise the least amount through the council tax precept, when that precept is the basis of the Government’s social care policy? East Riding Council, next to my own, can raise 56% more than Hull even though it has less demand.

[Jane Ellison]

As the hon. Lady knows, the better care fund, which we have already referred to, adjusts for that. We are responding to the pressures, which we acknowledge, in the social care system in a range of ways.

HMRC Estate

Debate between Jane Ellison and Diana Johnson

Tuesday 10th January 2017 Commons Chamber

[Jane Ellison]

It is worth noting on the broader point that employment in our countries is at an all-time high. We would always want to retain expertise within HMRC, but there will always be people leaving any large organisation and people being recruited and trained up simultaneously. I refer the hon. Gentleman to what I said earlier: it will be much easier to support people who want to join the organisation to become highly skilled and professional and to plot a career in HMRC, so that they can have long-term, fulfilling careers in a variety of different areas, under the new modernised structures.

[Diana Johnson (Kingston upon Hull North) (Lab)]

The Minister has said a number of times that there will be a better service for customers in these regional centres, but I note that the NAO report says that HMRC has not demonstrated that. Can she reassure me on how she has reached the conclusion that the service will be better, more efficient and more effective for customers?

[Jane Ellison]

I did note that point, but I am not sure that I agree with how the hon. Lady has expressed what I said. Let me provide one example. Many HMRC local offices are in very old buildings. As I said, some are over 100 years old and many are from the 1950s. Then there is the latest digital infrastructure, and many more taxpayers are interacting with HMRC digitally, through more than 7 million personal tax accounts. As anybody knows, it is difficult to bring an old office up to modern standards with the right digital infrastructure. If we want to make sure that staff can make the best use of modern computer systems and put them at the service of customers who increasingly interact digitally, it is much better to do so in newer buildings that have been bought for the purpose and where we have planned that sort of arrangement from the start.

Tax Credits: Concentrix

Debate between Jane Ellison and Diana Johnson

Wednesday 14th September 2016 Commons Chamber

[Jane Ellison]

It is really important that we get the facts of the case correct and quickly. At the point that that is done—it might be during the course of just one phone call—I am assured that money should be placed into people’s accounts in a matter of no more than four working days. That is what I expect to see. It is a matter of days and it certainly should not be weeks. We need to establish the facts in each instance. It is worth saying again—for the sake of the House having some sense of perspective on this issue—that last year only 1.6% of customers asked for a review of the decision, following a check. Given that a large number of people are being checked, that is quite a large number, but it would be wrong to think that this was a huge proportion of the cases in question. It is important to get things right and, as I say, we look to pay people within days—as soon as the facts of the case have been established.

[Diana Johnson (Kingston upon Hull North) (Lab)]

The Minister says that HMRC is supporting Concentrix in performing its contract up until it ends next year. What is the cost to the public purse of that support, and is it recoverable from Concentrix?

[Jane Ellison]

It has always been the case, as we would expect, that managers within HMRC have worked with Concentrix throughout. I do not anticipate that enormous additional costs will be involved. There has always been a relationship between the two because there is some overlap in the work being done. I would expect that to continue as we work towards the end of the contract.

NHS Commissioning (Pre-Exposure Prophylaxis)

Debate between Jane Ellison and Diana Johnson

Tuesday 7th June 2016 Commons Chamber

[Jane Ellison]

We would expect to get the evidence review that we have called for in the autumn. NHS England is already working on plans for the pilot programme, which will happen over a two-year period. We hope to get that under way towards the end of this year. Both those pieces of work are under way. We expect the pilots to be informed by the review, hence we want to get it back in a relatively short time.

[Diana Johnson (Kingston upon Hull North) (Lab)]

I am flabbergasted that the Minister has come before the House today to say that the legislation that her Government introduced on the reorganisation of the NHS was so incompetent that NHS England is having to go to court to work out who is entitled to commission these services. Can she tell us how much public money will be spent on the legal case?

[Jane Ellison]

I am not in a position to comment on that. I do not accept the hon. Lady’s central criticism. If she had been present at the Health Committee this morning, she would have heard an hour of evidence from myself, Duncan Selbie and Simon Stevens on how the new arrangements are making a significant difference to public health in this country and to the health of the public.

Contaminated Blood

Debate between Jane Ellison and Diana Johnson

Tuesday 12th April 2016 Commons Chamber

[Jane Ellison]

I am sorry. I have made a note in the margin of my speech to respond directly to the point made by the right hon. Gentleman, if I can get to it. I will try to deal with all the points that were made, and if I do not, I will write to Members after the debate.

The Scottish Government have chosen to provide a lump sum payment, and they currently have no proposals for annual payments to the hepatitis C stage 1 group. To give an idea of the difference, in England, over a five-year period, a stage 1 hep C sufferer who currently gets nothing but is awarded the highest proposed annual payment of £15,000 would receive £75,000. Officials from the Department of Health and the Scottish Government continue to exchange views on scheme reform, and we will reflect on the points that have been made today.

Let me touch briefly on the point about Wales and Northern Ireland. It is a matter for the Welsh and Northern Irish Governments to decide how support is provided for those infected in their areas, but they could opt to make the same reforms as the Department of Health and, indeed, participate in some administration arrangements following scheme reform. My officials hosted a meeting on 24 March with officials from each of the devolved Administrations to discuss scheme reform, and they will continue to work with their counterparts from the DAs on that.

Let me touch on treatment. I understand the points that have been made. Since I launched the consultation in January, the NHS has committed to doubling the number of patients treated with new therapies to 10,000 in 2016-17. NHS England has allocated £190 million from its budgets for 2016-17 for rolling out treatment with these new therapies. I will take into account this significant recent development, along with the responses to the consultation, when making decisions on treatment and payment for it from the scheme’s allocated fund when the consultation has closed. I have noted the clear steers Members have given me about treatment being taken forward by the NHS. I emphasise, however, that legally, the NHS cannot prioritise patients according to route of infection, and can only do so according to clinical need, as Members will understand.

Turning to where we go next, the outcome of the consultation will be crucial in informing our final decisions on how to proceed. We will analyse and reflect on all the responses, and although the scheduling of a debate is not in my gift I will seek to provide an opportunity for colleagues to discuss the proposals with me before any final decisions are made. I will continue to keep Opposition Front-Bench teams closely informed, as I have sought to do throughout. I give the House, and those affected, my commitment that we will proceed as rapidly as possible to implementation. However, I recognise that any reforms must be implemented in a measured way, to give those affected time to adjust, and at the same time ensure that there is no disruption to the provision of ongoing support.

I said when announcing the consultation that my intention was that the new annual payments for the current stage 1 cohort should be backdated to April—this month—regardless of when an individual’s assessment took place. I stress that we are very keen that any assessment is simple and light touch. We do not anticipate any interaction with the benefits system, but I will raise with the Department for Work and Pensions the points made by the hon. Member for Denton and Reddish (Andrew Gwynne) in his thoughtful contribution. We are aiming for simple, light-touch assessments every few years, and if someone’s health deteriorates we want to be able to respond appropriately.

I have tried to address some of the concerns, but I am conscious that I have not covered all of them. After the debate I will review them and respond if I can. I hope the right hon. Member for Manchester, Gorton (Sir Gerald Kaufman) will appreciate that I am not able to answer the points that he raised before the end of the debate.

The consultation will be genuinely open and I urge everyone with an interest to respond. I hope to take matters forward in a constructive and open way.

[Diana Johnson]

rose—

Infected Blood

Debate between Jane Ellison and Diana Johnson

Thursday 21st January 2016 Commons Chamber

[Jane Ellison]

I assure my hon. Friend that we will make every effort to reach people. My officials have already put in place extensive plans to publicise the consultation—they have met the heads of the charities and those running the current schemes, and will be writing to those who are registered with those schemes—and we will make it as easy as possible for people to get involved. One of our reasons for organising a 12-week consultation is that we recognise that some people may not be online, and we want to make sure that everyone has a chance to comment.

I will reflect on what my hon. Friend has said about direct contact. That may already be being pursued through some of our plans, but, as I have said, we have extensive plans to publicise the consultation, and it goes live today. Of course I shall welcome Members’ contributions on behalf of their constituents.

[Diana Johnson (Kingston upon Hull North) (Lab)]

I thank the Minister for her statement. I am sure that the all-party parliamentary group on haemophilia and contaminated blood will want to study the details in the coming weeks, and to take part in the consultation.

At first glance it appears that the Minister’s proposals are not as generous as those that are being discussed in Scotland, although I accept that as yet the Scottish Government have not accepted those proposals. However, I want to raise the specific issue of health assessments of those who are in stage 1 of hepatitis C. A number of those people have been living with the condition for a great many years, and even if their viral load is now cleared, they will not be able to resume their lives as if they had never been infected. Will the Minister assure me that that will be taken into account in any health assessments and in any subsequent financial arrangements?

[Jane Ellison]

Let me first thank the hon. Lady for all the campaigning work that she has done, for which she has rightly been recognised by others. Although we have not always been able to agree on everything, I have been greatly informed by what she has brought to our discussions, and I take on board many of the reports that the all-party group has produced over the years.

The recommendations that are being discussed in Scotland were made by a reference group and not by the Scottish Government, who have yet to respond to them. Shona Robison indicated that they would respond in due course, but that, obviously, is a matter for them.

It is a little too early to specify exactly how the individual health assessments will be carried out, but we will be asking an expert advisory group to advise on the criteria and the evidence. As I said in my statement, it is a question of recognising the impact of ill health, and also the fact that some people’s health fluctuates. I think that we can be assured that everyone will be included in the scheme, and that everyone will receive an annual payment. I should add that we expect people’s own clinicians to be involved in the individual assessments.

Victims of Contaminated Blood: Support

Debate between Jane Ellison and Diana Johnson

Wednesday 16th December 2015 Commons Chamber

[Diana Johnson (Kingston upon Hull North) (Lab)]

(Urgent Question): To ask the Minister responsible for public health to make a statement on Government plans to reform the support for victims of contaminated blood.

[The Parliamentary Under-Secretary of State for Health (Jane Ellison)]

I recognise that I committed in earlier debates to consulting on proposals to reform the current payment schemes before the end of the year. Despite our best efforts to meet that commitment, we are unfortunately not ready to publish the consultation before the recess. However, I confirm today that it will be published in January.

The delay will, I know, be disappointing for many who were anticipating the consultation before the end of the year. I apologise for the delay, in particular to Members of the House who have been campaigning tirelessly for a resolution on behalf of their constituents and to those who are directly affected, who continue to wait patiently for our proposals.

In the Westminster Hall debate in September, I explained that any consultation would happen within the context of the spending review and that payments for the reformed scheme would come from the Department of Health budget. The House will know that the outcome of the spending review was communicated to us only a few weeks ago.

The infected blood tragedy and reform of the payment schemes remain a priority for us. We are assessing what can be allocated above and beyond the additional £25 million to which we have already committed. That, of course, is in addition to the existing baseline spend on the payment schemes, which will remain.

Over my two years as public health Minister, I have heard regularly from those affected by this tragedy. Every week, I read a large number of letters, both to me and to the Prime Minister, from campaign groups, individuals and their families, all of whom have been affected by the tragedy in different ways. While considering our proposals for consultation, I want to ensure that all those views are reflected and that I do not miss the thoughts of those with the quieter voices.

We are currently working towards publication of the consultation, and, as part of that, we arranged an independently facilitated event with representatives of some of the leading campaign groups. The report from that event is available through those groups.

I have worked to keep Members of the House updated—you know how seriously I take my duties in that regard, Mr Speaker—and last month I invited members of the all-party group on haemophilia and contaminated blood to a meeting to discuss this issue. I told colleagues that my intention was to consult as soon as possible, but I said that that could be in January, given the timing of the comprehensive spending review.

As discussed with the all-party parliamentary group on haemophilia and contaminated blood, I am also interested in the opportunities offered by the advent of simpler and more effective treatments that are able to cure some people of hepatitis C, and which present a welcome new opportunity to make some people well. I assure the House that that work continues to establish a way forward, and a consultation will be published in January. At that time I will seek to make an oral statement.

In conclusion, because my priority is to get this issue right, I have taken the decision to take a little more time and publish the consultation in January.

[Diana Johnson]

Mr Speaker, your decision to grant this urgent question is recognition of the long campaign for justice for this group of people, and it is appreciated by everyone who has been involved. I am, however, disappointed that I have had to ask for an urgent question. On three occasions, Ministers promised a statement before Christmas, and they should not have been forced to come to the Chamber for the second time this year. When the Minister speaks about a consultation in January, I assume that she means January 2016. I would like clarification on that, because dates always seem to slip, and such action from the Government fuels distrust and resentment among people who have been let down for too long.

I have four questions for the Minister. First, she proposes a consultation that will run for 12 weeks and that she will need to assess before launching a new scheme. Will she explain how that is feasible before the start of the next financial year? Secondly, she claimed that it will be the first full public consultation, but the APPG ran a full consultation—with the same consultees—earlier this year. Can she assure me that she has considered the APPG report and all the evidence presented in it? Thirdly, as she said, the Government delayed making a statement until after the comprehensive spending review, in order to determine the total “financial envelope” available. I understand that the Department of Health currently pays out about £14 million a year, with a total future financial commitment of £455 million. Will the Minister tell the House how much more is now available following the comprehensive spending review?

Fourthly, lump-sum payments were a key issue raised in response to the APPG inquiry, but it now appears that those are off the agenda. That is a major disappointment because lump-sum payments would allow those affected to make real choices about their own lives—something they have been denied for far too long. Will the Minister support a separate request to the Treasury to use funds equivalent to the £230 million raised from the sale of Plasma Resources UK to fund lump-sum payments to those who have been affected?

[Jane Ellison]

I thank the hon. Lady for her response. Of course I understand the disappointment that we are not able to consult before the end of the year, but I informed her and her colleagues who came to the meeting on, I think, 5 November, that it was unlikely that we would be able to do so. That was recorded in the note made at the meeting, and published through the all-party group. I have tried to keep colleagues informed, and only last night I spoke to a number of campaigners about this issue, including the hon. Member for Foyle (Mark Durkan) and my hon. Friend the Member for Colne Valley (Jason McCartney), and informed them personally about the delay. I would, of course, have informed the hon. Lady today or tomorrow, along with the other Members who attended that meeting. I have done my best to keep people informed.

I understand the hon. Lady’s point about the consultation. I will consider the issue she raises, but I have always been clear that the transition to a new scheme must be done in a way that does not compromise the safety of payments to people in schemes—again, we discussed that at the meeting in early November. I therefore see no problem with consulting and then moving towards a transition, because that transition will be a gradual process anyway for some people. I want to ensure a safe transfer from the current scheme to any reformed scheme, and I do not see a real problem in that regard.

This will be the first full consultation by the Government, and the hon. Lady is right to say that the all-party group—and others, including my right hon. Friend the Member for North East Bedfordshire (Alistair Burt)—garnered many views. All views, including those put to the all-party group in its very good report, can be reiterated as part of the response to the consultation.

I made a statement on the issue of money in my response to the urgent question. I understand the point the hon. Lady makes on lump sum payments, but it would not be appropriate for me to comment at this time. I can talk about that more when I make an oral statement at the time we launch the consultation. She reiterated in her questions the principle of individual choice and treating people as individuals. Many Members have stressed to me the importance of that principle. We will very much recognise it in what we bring forward in the new year.

Penrose Inquiry

Debate between Jane Ellison and Diana Johnson

Thursday 26th March 2015 Commons Chamber

[Diana Johnson (Kingston upon Hull North) (Lab) (Urgent Question)]

To ask the Secretary of State for Health to make a statement on the publication of the Penrose inquiry and its implications for the United Kingdom Government.

[The Parliamentary Under-Secretary of State for Health (Jane Ellison)]

Yesterday the Prime Minister issued an apology for these tragic events on behalf of the Government, and my right hon. Friend the Secretary of State for Health laid a written ministerial statement as an interim response to the Penrose inquiry.

As the hon. Lady knows, this was a Scottish public inquiry. I understand that Scottish Ministers will not make a statement to their Parliament until this afternoon, and it would therefore be inappropriate for me to comment on the report in detail at this stage. However, I can say that Lord Penrose reviewed more than 118,000 documents and more than 150 statements from patients and relatives, and also took oral evidence from many of the officials who were involved in decision-making at that time. It seems to have been an extremely thorough job, and it has provided the first authoritative narrative of these events.

During the Back-Bench debate in the House on 15 January, I said that the Government would make an interim response to Lord Penrose’s report—which appeared yesterday, in the form of the written ministerial statement—and that it would be for the next Government to consider a more substantive response once they had had time to examine the findings of the inquiry.

Yesterday we announced that the Department of Health would allocate an additional one-off amount of up to £25 million from its 2015-16 budget to support any transition to a different system of financial assistance. We intended that announcement to provide an assurance for those who have been affected by these devastating events that we have heard their concerns and are making provision to reform the system. As the hon. Lady knows, we had hoped to consult during the current Parliament on reform of the ex gratia financial assistance schemes, and I very much regret that our considerations on the design of a future system of financial assistance for those affected were postponed while we awaited the publication of Lord Penrose’s final report.

The Prime Minister also said yesterday that if he was still Prime Minister after the election in May, his Government would respond to the findings of the report as a matter of priority.

[Diana Johnson]

Thank you for granting the urgent question, Mr Speaker. I thank the Minister for her response.

As we know, the contaminated blood scandal was the biggest disaster in the history of the NHS. Today we should again remember all those who contracted HIV and hepatitis C, and their families. For them, this is not an historical issue, but an ongoing tragedy which continues to have a devastating impact on their lives.

I am pleased that the report of the Penrose inquiry was published yesterday, after six years. It runs to five volumes and 1,800 pages, and it appears to document accurately the tragedy, how it came about, and the decisions that were made at the time. However, I share the surprise and disappointment of those affected that the report makes only one recommendation. I know that, for that reason, yesterday was a very difficult day for many people.

The Prime Minister’s apology on behalf of the United Kingdom Government represents a significant moment in the long struggle for recognition of the scale of the tragedy, and it is very welcome, but what we need is a proper system to support and compensate all those who are affected. The report that was published a few weeks ago by the all-party parliamentary group on haemophilia and contaminated blood shows that the current system is simply not meeting the needs of those whom it is meant to help, and is not fit for purpose. I should like to hear a reassurance from those on both Front Benches that, whichever party forms the next Government, swift action will be taken to provide a permanent support and compensation settlement. I should also like to be reassured that it will be specifically stipulated that the £25 million which was announced yesterday should go directly to the beneficiaries, rather than the trusts and funds deciding what to do with it.

This is not the end of the matter. As the Minister knows, a large number of Members on both sides of the House will return to it after 7 May, and will hold whoever is in power to account when it comes to sorting out this tragedy.

[Jane Ellison]

The hon. Lady is absolutely right to say that this is an ongoing tragedy, and that, as I said in my statement, many people’s lives have been devastated and continue to be severely affected. I pay tribute to her and to other members of the all-party group, including my right hon. Friend the Member for North East Bedfordshire (Alistair Burt), who cannot be present today but who has spoken to me in the last couple of days, since the publication of the report. Indeed, I pay tribute to all the Members who have represented their constituents so ably and passionately over many years.

As the hon. Lady said, the next Parliament will return to this issue. I was very open with Members during the Back-Bench debate on 15 January, and the hon. Lady knows that I am frustrated by the fact that we were not able to do more in the current Parliament. It is a matter of record from that debate that I spoke with Scottish Government Ministers in spring 2014 in anticipation that we would have an earlier report from the inquiry and that we might be able to move forward.

In response to the specific points the hon. Lady raised, let me reiterate something I said in my initial remarks: the one-off amount of up to £25 million is to support any transitional arrangements to a different system of financial assistance. That is intended to provide assurances to those affected by these devastating events that we have heard their concerns.

Tobacco Products (Standardised Packaging)

Debate between Jane Ellison and Diana Johnson

Thursday 3rd April 2014 Commons Chamber

[Jane Ellison]

I thank my hon. Friend for those comments. She is absolutely right to draw the House’s attention to the fact that the extent to which we can bear down on smoking and stop people taking it up the first place has a major impact on the sustainability of our health services and will, as she says, free up more resources to be spent on other things. It is a very important health priority. She is also right to allude to the impact of, for example, 4,000 children not taking up smoking. Even a modest impact on a major killer is really important.

[Diana Johnson (Kingston upon Hull North) (Lab)]

If the Minister is able to get the regulations past her own Back Benchers—and I note that the hon. Member for Hornchurch and Upminster (Dame Angela Watkinson) failed to declare an interest, as she registered hospitality from Japan Tobacco International on 12 June 2013—when will we see standardised packaging on the shelves? When will that be, should she get the regulations through in the last Session of this Parliament?

[Jane Ellison]

Once the Government have made a final decision—and in the event that that decision is to proceed and it is approved in this Parliament—there will be a transition period, as there always is with any tobacco regulations. Because we have not yet made a final decision, we have not decided what that period will be, but there would always be a sell-through period—that has been the precedent set in the past. We are not able to be absolutely definite at this point because of that sell-through period, but I am happy to talk to the hon. Lady about previous sell-through periods for similar legislation.